These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Experiences with the cytostatic tri-ethyleniminoquinone]. WOLF HJ; GERLICH N Verh Dtsch Ges Inn Med; 1959; 65():206-8. PubMed ID: 13845648 [No Abstract] [Full Text] [Related]
6. [Clinical experiences with the cytostatic drug Endoxan]. KOHOUT J Arzneimittelforschung; 1961 Mar; 11():218-20. PubMed ID: 13757614 [No Abstract] [Full Text] [Related]
7. [Clinical experiences with the cytostatic drug Endoxan]. SCHUELLER H Med Welt; 1962 Feb; 6():307-9. PubMed ID: 13909410 [No Abstract] [Full Text] [Related]
8. New methods to increase the effectiveness of cytostatic treatment. SELLEI CM Acta Unio Int Contra Cancrum; 1960; 16():916-8. PubMed ID: 14444730 [No Abstract] [Full Text] [Related]
9. [Clinical experiences with vincaleukoblastine (Velbe), a new cytostatic]. KEISER G; BRUNNER K; MARTZ G Schweiz Med Wochenschr; 1962 Apr; 92():486-93. PubMed ID: 14454863 [No Abstract] [Full Text] [Related]
10. [Therapy with cytostatic substances in carcinomas and sarcomas in the realm of the radiation clinic]. SCHERER E Strahlentherapie; 1959; Suppl 43():254-9. PubMed ID: 14442646 [No Abstract] [Full Text] [Related]
11. [On the cytostatic therapy of plasmocytoma]. FASS H Med Monatsschr; 1962 Jun; 16():389-93. PubMed ID: 13891742 [No Abstract] [Full Text] [Related]
12. Comparative clinical studies with new cytostatic agents. ECKHARDT A Acta Unio Int Contra Cancrum; 1960; 16():842-5. PubMed ID: 13819224 [No Abstract] [Full Text] [Related]
13. [Contribution to the study of the action of cytostatic E 39 on epitheliomas]. GROS CM; KEILING R; LE GAL Y Sem Hop Ther Paris; 1960 Apr; 36():312-5. PubMed ID: 13829597 [No Abstract] [Full Text] [Related]
14. [Problems in chemotherapy illustrated by the cytostatic 5-fluoruracil and the leukemias]. OBRECHT P Strahlentherapie; 1961; Suppl 48():65-73. PubMed ID: 14481028 [No Abstract] [Full Text] [Related]
15. [Degeneration of a metastasizing dysgerminoma by cytostatic treatment]. THEISEN H Geburtshilfe Frauenheilkd; 1961 Jan; 21():77-9. PubMed ID: 13776200 [No Abstract] [Full Text] [Related]
16. [Cytostatic therapy of choroid metastases with Bayer E-39 (soluble) and 3231 (Development of bilateral pupillotonia)]. LIEGL O Klin Monbl Augenheilkd Augenarztl Fortbild; 1960; 136():185-95. PubMed ID: 13848550 [No Abstract] [Full Text] [Related]
17. [5 years of cytostatic therapy in malignoma of the thoracic space. (1. Experience report with early results)]. ADELBERGER L; WOERN H Krebsarzt; 1962 Feb; 17():51-67. PubMed ID: 13859384 [No Abstract] [Full Text] [Related]
18. [Initial results in the palliative treatment of malignant processes in their terminal phases using the new cytostatic agent LH/22]. LLOMBART A; ESPINOSA J; JUAN-MARCO A Rev Clin Esp; 1961 Oct; 83():32-9. PubMed ID: 14466038 [No Abstract] [Full Text] [Related]
19. [Treatment with cytostatic substances in carcinomas and sarcomas within the scope of the radiation clinic]. SCHERER E Fortschr Geb Rontgenstr Nuklearmed; 1959; 90(Suppl)():22. PubMed ID: 14442647 [No Abstract] [Full Text] [Related]
20. [Cytostatics and the special indications for their use]. TOUSSAINT R J Int Coll Surg; 1961 Dec; 36():812-4. PubMed ID: 13922172 [No Abstract] [Full Text] [Related] [Next] [New Search]